Intended for healthcare professionals

CCBYNC Open access

Rapid response to:

Research

Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e8343 (Published 17 December 2012) Cite this as: BMJ 2012;345:e8343

Rapid Response:

Re: Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration

We reviewed your interesting article about the efficacy of non-benzodiazepine hypnotics in the treatment of insomnia in adults. Nowadays there is a global increase in life expectancy in the adult population, especially older people in whom insomnia is a health problem and difficult to manage both diagnostically and therapeutically. We share with you the effectiveness of non-benzodiazepine hypnotics particularly Zolpidem in such treatment, always starting with low doses and increasing the dose depending on the clinical response.

Moreover we cannot forget sleep disorders as an expression of organic problems. All therapy is not without side effects, but we have to determine the risks before prescribing for each patient. The most frequent reactions reports in our series include mental confusion, falls with a range of complications. Patient assessment related to their environment, family functioning, crisis life cycle are elements to take into consideration in an adult with insomnia. Psychological support of the patient by family members, caregivers, healthcare team as well as the use of natural medicine have given us excellent results in the management of patients with insomnia.

Competing interests: No competing interests

29 April 2014
Jose Maximo Carles Zerquera
Medicina Interna
Dra Maria G Ruiz Gonzalez, Lic Ihosvany Castellanos Santos, Dra Sorahy Santander Garcia, Dra Iris Carmenate Rodriguez, Dr Ariel Salgado Sansaric
Policlinico Universitario Manuel Lara Cantero
Simon Bolivar 306 Trinidad Cuba